Delivery Order SPE2DB22D1103-SPE2DB25FTRM5
Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,342.85 to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 ml syringes on September 11, 2025, with completion scheduled for September 12, 2025. EUFLEXXA is a hyaluronic acid-based injectable treatment commonly used for knee osteoarthritis pain management. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,891.11 to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes (2 mL quantity) on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. EUFLEXXA is a hyaluronic acid injection used for osteoarthritis treatment,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes with a ceiling value of $3,670.26. EUFLEXXA is a hyaluronic acid-based injectable treatment used for knee osteoarthritis pain management. This competitive delivery order, executed under firm fixed pricing, represents a continuation of the federal medical procurement relationship between the prime contractor and the...
- The Defense Logistics Agency awarded a $4,680.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes (2 mL quantity) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,891.21 to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 ml syringes (2 ml units) with an ultimate completion date of October 29, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $23.6K delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 MG/2 ML syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA, leveraging the company's position as a critical distributor of medical products for federal healthcare systems. The award carries no...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes with a ceiling value of $3,090.60. EUFLEXXA is a hyaluronic acid-based injectable product used for osteoarthritis treatment. This non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,745.36 to AmerisourceBergen Drug Corp for the supply of EUFLEXXA 1% 20 mg/2 mL syringes on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. EUFLEXXA is a hyaluronic acid-based injectable product used for osteoarthritis treatment, representing...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes in 2 ml quantities. This is a firm fixed price delivery order with a ceiling value of $2,575.50 and an ultimate completion date of July 30, 2025. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. EUFLEXXA is a viscosupplementation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes with a ceiling value of $6,754.59 on August 14, 2025. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and no set-aside designation was used. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...